Methylprednisolone Adjunctive to Endovascular Thrombectomy for Stroke
A phase 3 trial registered on ClinicalTrials.gov. The registry status is active, not recruiting. It enrolled 928 participants.
Also called NCT06360458
- Study
- In this atlas
Overview
- Design
- Interventional study; randomized; quadruple masking; primary purpose treatment
- Phase
- Phase 3
- Enrolled
- 928 participants
- Sponsor
- Wan-Jin Chen
- Registry
-
NCT06360458
-
- Started
- (actual)
- Primary completion
- (actual)
- Completion
- (anticipated)
- Countries
- China
- Registry status
- Active, not recruiting
Technical summary
Registry record NCT06360458. Randomized; quadruple masking; primary purpose treatment. Start 2024-08-01 (actual); primary completion 2025-09-30 (actual). Results not posted.
The registry's words
Labels as the registry gives them, not rewritten.
- Brief title
- Methylprednisolone Adjunctive to Endovascular Thrombectomy for Stroke
- Acronym
- MIRACLE
- Condition
- Acute Ischemic Stroke
- Condition
- Large Infarct Core
- Intervention (Drug)
- Methylprednisolone sodium succinate
- Intervention (Drug)
- Placebo
- Lead sponsor
- Wan-Jin Chen
Record details
- Record id
cardio:ct-nct06360458- Content hash
d38fe7fed1f4a14e677beeca1c42d154cb5f2da898066f41498c2531cfc4a98b